New first-line option for patients with pMMR and dMMR tumours in England
Category: News
New oral GLP-1 agonist aims to reshape chronic weight management
FDA validation and AI-designed therapies mark major shift in treatment strategy
New drug delivery system could transform treatment for chronic conditions
Dydrogesterone-only tablet returns after 17-year absence to support personalised care
US$30.9 million strategic equity deal strengthens oncology platform
MB310 study investigates safety and efficacy of precision microbiome therapy
Four-year treatment slows cognitive decline with consistent safety profile
Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season